Supraphysiological level of estrogen exposure in vivo increases lymphoid cell death in mice

Abstract

Estrogen can enhance or reduce lymphocyte functions in vitro depending on dose and exposure duration. The purpose of this study was to determine the effect of in vivo 17β-estradiol (E2) on apoptosis and necrosis in lymphoid tissue of female C567BL/6 mice. Animals were ovariectomized (OVX), ovariectomized and 17β-estradiol supplemented (OVX+E2; 71 μg E2 per day for 14 days), sham ovariectomized (SHAM), or unhandled controls (CONTROL). Thymus and spleen were removed aseptically, cells dispersed into single cell suspensions in RPMI-1640, and measures of cell damage performed: an annexin V flow cytometric assay for markers of apoptosis and an enzyme-linked immunoassay for measures of DNA fragmentation and necrosis. OVX + E2 mice had 620 ± 72 pg/ml 17β-estradiol in serum in contrast to OVX mice which had 7.6 ± 5 pg/ml, the SHAM mice which had 2.8 ± 1 pg/ml of serum E2, and the CONTROL mice which had 3.9 ± 0.8 pg/ml of serum E2 ( p < 0.001). There was a significantly lower percentage of viable thymocytes in OVX+E2 mice compared to the other treatment conditions ( p < 0.001, respectively). There was also a significantly higher percentage of annexin V positive thymocytes in OVX+E2 mice ( p < 0.005). Measures of DNA fragmentation by ELISA were higher in splenocytes from OVX+E2 mice than in the OVX, SHAM or CONTROL mice ( p < 0.005). These results suggest that supraphysiological levels of estrogen in vivo induce damage in lymphoid cells; however, the impact of estrogen associated lymphoid tissue damage on specific immune functions remains to be determined.